Additionally, P2Y12 inhibition appeared to reverse some of the platelet-mediated immune evasion by tumor cells and disrupt tumor cell–induced platelet aggregates, which may be important for hematogenous metastasis (145,151). Here, P2RY12 is linked to neoplasm.